A09
Project Area A - Biology and Molecular Oncology
Prof. Dr. Christian Reinhardt
Clinic for Hematology and Stem Cell Transplantation
University Hospital Essen
Phone: +49 201 723 3136
Email
Targeting oncogene-induced DNA repair pathway switches
Reinhardt has identified a cell state transition in KRAS-driven non-small cell lung cancer cells that features a critical change in DNA damage repair competence accompanied with increased mutational burden and altered cancer drug sensitivities. He will unravel the molecular role of proteins of the ubiquilin family that mediate this transition, identify the gene regulatory elements that trigger ubiquilin overexpression and dissect the mechanism and additional targets of the ubiquilins using proteomics. In addition to these mechanistic studies, he will determine thera-peutic vulnerabilities in vitro and in mouse models.
Project Members
Dr. Sebastian Klein
Publications
-
Cranioencephalic functional lymphoid units in glioblastomaIn: Nature Medicine (2024) in pressOnline Full Text: dx.doi.org/ (Open Access)
-
Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCRIn: European Journal of Haematology Vol. 112 (2024) Nr. 6, pp. 957 - 963Online Full Text: dx.doi.org/ (Open Access)
-
Distinct genetically-determined origins of Myd88/Bcl2-driven aggressive lymphoma rationalize targeted therapeutic intervention strategiesIn: Blood Cancer Discovery Vol. 4 (2023) Nr. 1, pp. 78 - 97Online Full Text: dx.doi.org/ (Open Access)
-
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanomaIn: Nature Cancer Vol. 4 (2023) Nr. 9, pp. 1292 - 1308Online Full Text: dx.doi.org/ (Open Access)